Safety and tolerability of apomorphine sublingual film and subcutaneous apomorphine for the treatment of OFF episodes in Parkinson's disease

被引：0

|

作者：

Rascol, O.

Poewe, W.

Stocchi, F.

Chaudhuri, R.

Kassube, J.

Manzanares, L. Lopez

Leta, V.

Zhang, I.

Bowling, A.

Wu, S.

Pappert, E.

机构：

来源：

MOVEMENT DISORDERS | 2022年 / 37卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

760

引用

收藏

页码：S348 / S348

页数：1

相关论文

共 50 条

[41] Efficacy of sublingual apomorphine (APL-130277) for the treatment of "Off" episodes in patients with Parkinson's disease
Hauser, R. A.
Dubow, J.
Dzyngel, B.
Bilbault, T.
Giovinazzo, A.
Agro, A.
EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 249 - 249
[42] Indirect Comparison of Apomorphine Sublingual Film Versus Levodopa Inhalation Powder for "OFF" Episodes in Parkinson's Disease
Thach, A.
Zichlin, M.
Kirson, N.
Yang, K.
Gaburo, K.
Pappert, E.
Mehta, D.
Williams, G.
MOVEMENT DISORDERS, 2021, 36 : S197 - S197
[43] Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson's Disease: Is the Prophylactic Use of an Antiemetic Necessary?
Hauser, Robert A.
Ondo, William G.
Zhang, Yi
Bowling, Alyssa
Navia, Bradford
Pappert, Eric
Isaacson, Stuart H.
JOURNAL OF PARKINSONS DISEASE, 2023, 13 (03) : 403 - 414
[44] Apomorphine Sublingual Film for OFF Episodes in Parkinson's Disease: Incremental Motor Improvement Observed with Increasing Doses
Isaacson, S.
Zhang, I.
Pappert, E.
Bowling, A.
MOVEMENT DISORDERS, 2022, 37 : S334 - S335
[45] Apomorphine Sublingual Film for "OFF" Episodes in Parkinson's disease: Characterization of Acute Nausea During Dose Titration
Ondo, W.
Hauser, R.
Bowling, A.
Isaacson, S.
Pappert, E.
Navia, B.
MOVEMENT DISORDERS, 2021, 36 : S189 - S189
[46] Apomorphine Sublingual Film for On-Demand Treatment of "OFF" Episodes in Patients With Parkinson's Disease: Impact on Impulse Control Disorders
Espay, A.
Markopoulou, K.
Bhargava, P.
Navia, B.
MOVEMENT DISORDERS, 2020, 35 : S394 - S394
[47] Long-Term Safety and Efficacy of Apomorphine Sublingual Film for "OFF" Episodes in Parkinson's disease: Europe vs North America
Pahwa, R.
Fox, S.
Hui, J.
Singer, C.
Schwarz, J.
De Pandis, M. F.
Raw, J.
Zhang, I.
Pappert, E.
Navia, B.
MOVEMENT DISORDERS, 2021, 36 : S189 - S189
[48] Onset of action of intermittent subcutaneous apomorphine in the treatment of "off" episodes in patients with advanced Parkinson's disease
Hull, KL
Gutman, L
MOVEMENT DISORDERS, 2004, 19 : S216 - S216
[49] Sublingual apomorphine in treatment of Parkinson's disease: a review
Hislop, Jennifer
Margolesky, Jason
Shpiner, Danielle S.
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024, 134 (05) : 474 - 480
[50] EXPOSURE-RESPONSE EFFICACY MODEL OF APOMORPHINE SUBLINGUAL FILM FOR THE ON-DEMAND TREATMENT OF "OFF" EPISODES IN PATIENTS WITH PARKINSON'S DISEASE
Agbo, F.
Chiu, Y. -Y.
Chapel, S.
Navia, B.
PARKINSONISM & RELATED DISORDERS, 2020, 79 : E85 - E86

← 1 2 3 4 5 →